Skip to content
10-K

Annual Report

European Biotech Acquisition Corp.

0001193125-23-051721

← back to feed
Filed
Feb 28, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Operating Cash Flow FY 2022 · Dec 31, 2022 −$514.79K
Operating Cash Flow FY 2022 · Dec 31, 2021 −$688.83K
Cash And Equivalents FY 2022 · Dec 31, 2022 $308.49K
Cash And Equivalents FY 2022 · Dec 31, 2021 $868.28K
Stockholders Equity FY 2022 · Dec 31, 2022 −$8.06M
Stockholders Equity FY 2022 · Dec 31, 2021 −$6.69M
Stockholders Equity FY 2022 · Jan 7, 2021 $0
Current Liabilities FY 2022 · Dec 31, 2022 $795.57K
Current Liabilities FY 2022 · Dec 31, 2021 $505.2K
Total Liabilities FY 2022 · Dec 31, 2022 $8.55M
Total Liabilities FY 2022 · Dec 31, 2021 $7.61M
Current Assets FY 2022 · Dec 31, 2022 $356.64K
Current Assets FY 2022 · Dec 31, 2021 $916.47K
Total Assets FY 2022 · Dec 31, 2022 $129.75M
Total Assets FY 2022 · Dec 31, 2021 $128.47M
Sga Expense FY 2022 · Dec 31, 2022 $2.59M
Sga Expense FY 2022 · Dec 31, 2021 $912.1K
Net Income FY 2022 · Dec 31, 2022 $342.9K
Net Income FY 2022 · Dec 31, 2021 $1.48M
Operating Income FY 2022 · Dec 31, 2022 −$2.82M
Operating Income FY 2022 · Dec 31, 2021 −$1.1M